Policies and Procedures

 Open Access Policy

This journal provides immediate open access to its content, based on the principle that providing open access to research helps a greater global exchange of knowledge. Those authors who have publications with this magazine, accept the following terms:

  • The authors will retain their copyright and will guarantee to the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution License that allows third parties to share the work with the correct citation regarding the author and the Journal of Ciencia e Innovación en Salud.
  • Authors may adopt other non-exclusive license agreements to distribute the version of the published work (e.g: to be deposited in an institutional telematic file or published in a monographic volume) provided the initial publication is indicated in this journal.
  • Authors are encouraged to disseminate their work via the Internet (e.g: in institutional telematic files or on their website) before and during the submission process, which can produce interesting exchanges and increase the number of citations of the published work. 


Membership and Article Fee

The corresponding author (s) must have at least a free OJS account at the time of submission. The authors and co-authors must sign a cover letter and confirmation of authorship. Remember to check your spam folder. 

Exemption Policy: The Universidad Simón Bolívar de Barranquilla and the new editorial team wants to help researchers around the world to publish their work; so if you work at a legally recognized university in your country, or if you belong to a health sciences related institution or organization fully registered in the presentation or cover letter, your Open Access article processing charge or publication fee is FREE.


Author Policies

The Corresponding Author’s Role and Responsibilities are to:

  1. Inform all co-authors of the submission of the manuscript to the journal (note: each co-author must sign the presentation or cover letter and confirm their authorship).
  2. Ensure that the manuscript is in full adherence to all Health Science and Innovation policies. Additionally ensure that all co-authors are aware of, and in compliance with all of them.
  3. Manage all correspondence between the journal and all co-authors, keeping the full co-authors group apprised of the manuscript progress.
  4. Designate a substitute correspondent for times of unavailability
  5. Ensure to fill out all required points at the time of submission of the manuscript.
  6. Post-publication: respond to all queries pertaining to the published manuscript, provide all data and requested materials.
  7. The submission must be created (and completed) by one of the co-authors, not by an agency or by some other individual who is not one of the co-authors

 Ciencia e Innovación en Salud adheres to the ICMJE requirements.



Ciencia e Innovación en Salud keeps all details about a submitted manuscript confidential, does not publicly comment about submitted or rejected manuscripts and maintains reviewer confidentiality unless given permission to reveal identities. Authors, reviewers and editors must also treat correspondence as confidential unless explicitly stated otherwise.


Publication Ethics

  1. Ciencia e Innovación en Salud adheres to the prevailing industry standards and procedures for investigating publication ethics.
  2. Ciencia e Innovación en Salud not allow dual publication (the same material published twice in the peer reviewed literature), or dual submission (the same material simultaneously submitted to more than one journal).
  3. Ciencia e Innovación en Salud does not tolerate plagiarism, data or figure manipulation, knowingly providing incorrect information, copyright infringement, inaccurate author attributions, attempts to inappropriately manipulate the peer review process, failures to declare conflicts of interest, fraud, and libel. The journal follows the rules of the Committee on Publication Ethic (COPE) and the World Association of Medical Editors (WAME), among others.
  4. In extreme cases, this may call for individuals to be reported to their institutions and/or for manuscripts to be retracted. Any complaints should be directed to editorial.support@revcis.com


Committee on Publication Ethics (COPE)

Ciencia e Innovación en Salud adheres to the COPE Code of Conduct and Best Practice Guidelines. We follow recommended COPE procedures whenever we are alerted to an issue which requires investigation.


Competing Interests

  1. Ciencia e Innovación en Salud requires that all parties involved in a publication (i.e. the authors, reviewers and academic editors) should transparently declare any potential Competing Interests (also known as Conflicts of Interest). The disclosure of a Competing Interest does not necessarily mean that there is an issue to be addressed; it simply ensures that all parties are appropriately informed of any relevant considerations while they work on the submission.
  2. Authors are asked to declare all competing interests upon submission. Reviewers are expected to consider any competing interests before agreeing to review, and to confirm that they have no competing interests before submitting their review. Academic Editors are expected to recuse themselves from handling a manuscript if they feel they have a competing interest.
  3. Potential competing interests should be declared even if the individual in question feels that these interests do not represent an actual conflict. 
  4. The authors must declare any possible financial benefit with the publication.


Funding Disclosure

  1. Ciencia e Innovación requires that authors disclose the financing which made their work possible.
  2. The Funding statement is published in the final article. This disclosure provides added transparency.


Ethics Statement

  1. Where applicable, Ciencia e Innovación en Salud requires that authors provide an Ethics statement which details the relevant ethical standards which were met when conducting the research.
  2. Ethics statements are required whenever research is conducted on humans or human tissue; on animals or animal tissue; when conducting field studies; or whenever the approval of an Institutional Review Board (IRB) or Institutional Ethics Committee (ERC) was required.
  3. In addition to providing an Ethics statement upon submission (for review purposes), this same statement should also be provided in the Materials and Methods section of the manuscript.
  4. Where IRB or ERC approval was required, the authors must provide an ethics statement as part of their Materials and Methods section detailing full information regarding their approval (including the name of the granting organization, and the approval reference numbers).?? If an approval reference number is not provided, written approval must be provided as confidential supplemental file.


Data and Materials Sharing

Ciencia e Innovación en Salud is committed to improving academic communications and as part of this commitment, all authors are responsible for making available (at an early stage) the materials, code, data and protocols associated with its publication. The preferred way to comply with this requirement is to make a public deposit.  Example: https://figshare.com/


Reporting and Research Guidelines

  1. We require authors to adhere to the reporting standards which have been adopted by their field and apply to their study design.
  2. Authors should indicate which standards were followed and should as part of their article submission.


Discipline Specific Standards

See the accepted subjects for submission by the journal. 


Animal Research 

For experiments involving human subjects, appropriate approval must have been obtained from the relevant approval body (in most cases the authors’ Institutional Review Board, or ethics committee). 


Human Research

  1. The authors must provide an ethics statement as part of their Materials and Methods section detailing full information regarding their approval (including the name of the granting organization, and the approval reference numbers). If an approval reference number is not provided, written approval must be provided as a confidential supplemental information file. Any research must have conformed to the Declaration of Helsinki. If an approval was not obtained, the authors must provide a statement explaining why it was not needed.
  2. Authors must include a statement confirming that informed consent was obtained from all subjects. If consent was written, an empty copy of the consent form used should be provided as a Confidential Supplemental Information file.
  3. Individual privacy and anonymity must be protected. Identifying information (such as names, photographs, identifying data) should not be included in the manuscript. Exceptions can be made only when evidence is provided that the individuals in question have given explicit approval. More information about individual privacy, anonymity, and informed consent can be found in the ICMJE.


Reviewer and Editor Blinding

  1. Authors may request that specific individuals be prevented from seeing their submission (a practice known as 'blinding').
  2. Requests to blind individuals should be limited in nature, should refer to specific individuals (not broad lists or categories of people), and should be made only with good reason.
  3. While we will attempt to honor these requests, we cannot guarantee that all requests will be honored.



  1. If an author feels strongly that an inappropriate decision has been made on their decision, then Ciencia e Innovación en Salud allows them to make a single Appeal.
  2. Appeals must be submitted with detailed information as to why the original decision was in error. 
  3. We will first approach the original academic editor and determine whether, in light of this feedback, they now wish to change their mind. If they do not, then a second Academic Editor (or in some cases a committee of Academic Editors) will be asked to make an adjudication. In some cases this may involve re-review of the article.
  4. The new decision is considered final.
  5. Authors should be aware that Appeals often take some time to be resolved.


Blogs, Embargoes, and Media

  1. Ciencia e Innovación en Salud does not consider articles which have previously appeared in a recognized peer reviewed journal (as this represents dual publication).
  2. Ciencia e Innovación en Salud accepts submissions which have previously appeared on preprint servers; have previously been presented at conferences; or have previously appeared in other ‘non journal’ venues (for example: blogs or posters).
  3. We encourage authors to discuss and disseminate their findings as they wish. If they are discussing submissions which have not yet been formally accepted, then they should state this fact.


Copyright Permissions

  1. Ciencia e Innovación en Salud publishes accepted manuscripts under a  Creative Commons CC BY 4.0 license.
  2. It is the author’s responsibility to obtain the appropriate permissions from the original publisher to republish any previously published text, figures, tables, Supplementary Information, etc., in an Open Access journal under a Creative Commons CC BY 4.0 license.


Retraction Policy

Ciencia e Innovación en Salud reserves the right to retract articles which are found to be fraudulent (for example subject to deception such as data manipulation) or in serious breach of one of our policies.



Ciencia e Innovación en Salud is governed by the laws of the World Intellectual Property Organization, which is applied in Colombia through the decision 351 of 1993 of the commission of the Cartagena Agreement and Law 23 of 1982. For this reason, all articles submitted to journal will be checked using a software that indicate plagiarism.



This journal uses the LOCKSS system to create a file system distributed among collaborating libraries, which allows the creation of permanent files of the journal for conservation and restoration purposes.